REGISTERED
on 09 Jun 2020
Last Applicant/ Owned by
86 Morris Avenue
Summit
NJ
07901
Serial Number
88655362 filed on 15th Oct 2019
Registration Number
6073615 registered on 09th Jun 2020
Correspondent Address
Marilyn F. Kelly
Filing Basis
1. use application currently
Disclaimer
NO DATA
R2 REVLIMID/RITUXIMAB
Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab Medical information and counseling in the field of pharmaceuticals and safety issue Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the treatment of certain cancers; pharmaceutical preparations for the treatment of lymphoma; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all the aforementioned goods being comprised in part of rituximab
First Use Date in General
28th May 2019
First Use Date in Commerce
28th May 2019
Class [044]
Medical, Beauty & Agricultural Services
Medical information and counseling in the field of pharmaceuticals and safety issues pertaining to pharmaceuticals, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; programs in the nature of providing medical information and counseling in the field of lenalidomide and rituximab and safety issues pertaining to lenalidomide and rituximab, and providing medical information in the aforementioned fields by distributing written materials in connection therewith; providing a web site featuring medical information; providing an internet website for medical professionals and medical patients featuring medical information; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing pharmaceutical advice; providing medical information, consultancy and advisory services; all the aforementioned services relating to rituximab
First Use Date in General
28th May 2019
First Use Date in Commerce
28th May 2019
Mark Details
Serial Number
No 88655362
Mark Type
No Service Mark
Attorney Docket Number
No CELG2019US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.17.01 -
Straight line(s), band(s) or bar(s)
26.17.06 -
Diagonal line(s), band(s) or bar(s)
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Dec 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 09th Dec 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 09th Dec 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 09th Dec 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 09th Dec 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 09th Dec 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 09th Jun 2020 | REGISTERED-PRINCIPAL REGISTER |
| 24th Mar 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 24th Mar 2020 | PUBLISHED FOR OPPOSITION |
| 04th Mar 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |